A Randomized Phase I Study of Testosterone Replacement for Patients with Low Risk Castrate Resistant Prostate Cancer

BACKGROUND: The androgen pathway remains biologically relevant even in castration resistant prostate cancer (CRPC). In preclinical models, androgen therapy for CRPC leads to growth arrest, apoptosis, and tumor shrinkage. This study determined the toxicity and feasibility of a testosterone therapy in...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Szmulewitz, Russell, Mohile, Supriya, Posadas, Edwin, Karrison, Rangesh Kunnavakkam Theodore, Manchen, Elizabeth, Stadler, Walter M.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2009
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2885777/
https://ncbi.nlm.nih.gov/pubmed/19282098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2009.02.022
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन